In recent decades, cancer treatment costs have outpaced the general inflation rate The costs are now so exorbitant as to easily bankrupt the average family. Cancer now often puts patients and their families in a quandary. The options open to them are eith
Michael Green and the Importance of Measuring Progress Michael Green, Executive Director of the Social Progress Imperative (SPI), delivers the Institute and Faculty of Actuaries’ (IFoA) annual Spring Thought-Leadership Lecture on what ‘social
Speaker: Elsa Renouf, Chairperson ERM Committee Institut des Actuaires (France) Elsa focusses on how the ORSA is used to affect the perspective of the organisation on an ongoing basis . She discusses the potential of the ORSA to produce an outcome that ca
Speaker: David Hare, chairperson AAE ESAP3 Task Force David speaks about the development of ESAP3 on Actuarial practice in relation to the ORSA process under Solvency II, which was issued by the AAE on 2 August 2017. He explains the principles followed in
Ibrahim Muhanna and Rainer Fürhaupter on the IAA/VICA Bursary Program
Speaker(s): Clemens Frey Extract from the webinar AAE Webinar on ORSA and ESAP 3 Clemens Frey speaks about the ORSA process in general, including the objectives, which parties are involved and the technical difficulties associated with the ORSA process. H
Speaker(s): Hans-Jochen Bartels (University of Mannheim), Johannes Bartels (BaFin) This contribution considers the capital requirements for portfolios of ordinary life annuity contracts under the regime of Solvency II (SII).
This user hasn't shared anything yet.
Videos appear on this list if these have been watched during one logged-in session for at least 90% of the full length. Logging out or closing the browser sets the corresponding counter back to 0%
|Viewed on||Video Name||Duration viewed (%)|